Entero Therapeutics Inc (ENTO)
2.74
+0.11
(+4.18%)
USD |
NASDAQ |
May 31, 16:00
2.75
+0.01
(+0.36%)
After-Hours: 20:00
Entero Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2020 | 0.0874M |
September 30, 2020 | -0.0097M |
June 30, 2020 | -0.0136M |
March 31, 2020 | -0.0151M |
December 31, 2019 | -0.0241M |
September 30, 2019 | -0.2744M |
June 30, 2019 | -0.2778M |
March 31, 2019 | -0.2893M |
December 31, 2018 | -0.3055M |
September 30, 2018 | -0.0486M |
June 30, 2018 | -0.052M |
Date | Value |
---|---|
March 31, 2018 | -0.0611M |
December 31, 2017 | -0.0322M |
September 30, 2017 | -0.0312M |
June 30, 2017 | -0.022M |
March 31, 2017 | -0.012M |
December 31, 2016 | -0.0124M |
September 30, 2016 | -0.0176M |
June 30, 2016 | -0.0229M |
March 31, 2016 | -0.0143M |
December 31, 2015 | -0.0244M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.2778M
Minimum
Jun 2019
0.0874M
Maximum
Dec 2020
-0.0753M
Average
-0.0151M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
BioVie Inc | 12.73M |
Jaguar Health Inc | -- |
Benitec Biopharma Inc | -0.18M |
Immuneering Corp | 9.717M |
NovaBay Pharmaceuticals Inc | 1.062M |